FDA grants approval to Diamyd to initiate phase III clinical study of Diamyd in diabetes March 18, 2008
Lilly and Transition enter agreement for TT-223 and other gastrin-based therapies in diabetes March 18, 2008
FDA recommends approval of Amgen's BLA for romiplostim in immune thrombocytopenic purpura March 17, 2008
RSS